668 related articles for article (PubMed ID: 3527304)
21. [Current status and prospectives of aromatase inhibitors in the treatment of advanced breast cancer].
Boccardo F
Minerva Ginecol; 1998 Mar; 50(3):51-63. PubMed ID: 9595916
[TBL] [Abstract][Full Text] [Related]
22. [Chemical adrenalectomy induced by aminoglutethimide in the treatment of breast cancer. A review].
Cikes M
Schweiz Med Wochenschr; 1983 Mar; 113(11):382-91. PubMed ID: 6342129
[TBL] [Abstract][Full Text] [Related]
23. Estrogen synthesis in human breast tumor and its inhibition by testololactone and bromoandrostenedione.
Dao TL
Cancer Res; 1982 Aug; 42(8 Suppl):3338s-3341s. PubMed ID: 7083197
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of estrone sulfatase and proliferation of human breast cancer cells by nonsteroidal (p-O-sulfamoyl)-N-alkanoyl tyramines.
Selcer KW; Hegde PV; Li PK
Cancer Res; 1997 Feb; 57(4):702-7. PubMed ID: 9044848
[TBL] [Abstract][Full Text] [Related]
25. Tamoxifen therapy of metastatic breast cancer.
Manni A
J Lab Clin Med; 1987 Mar; 109(3):290-9. PubMed ID: 2950193
[TBL] [Abstract][Full Text] [Related]
26. Endocrine management of breast cancer.
Schneider PG; Jackisch C; Brandt B
Int J Fertil Menopausal Stud; 1994; 39 Suppl 2():115-27. PubMed ID: 7874188
[TBL] [Abstract][Full Text] [Related]
27. Aromatase in breast cancer and the role of aminoglutethimide and other aromatase inhibitors.
Brodie AM; Santen RJ
Crit Rev Oncol Hematol; 1986; 5(4):361-96. PubMed ID: 3094971
[TBL] [Abstract][Full Text] [Related]
28. Phase II study of vorozole (R83842), a new aromatase inhibitor, in postmenopausal women with advanced breast cancer in progression on tamoxifen.
Goss PE; Clark RM; Ambus U; Weizel HA; Wadden NA; Crump M; Walde D; Tye LM; De Coster R; Bruynseels J
Clin Cancer Res; 1995 Mar; 1(3):287-94. PubMed ID: 9815984
[TBL] [Abstract][Full Text] [Related]
29. Randomized trial of aminoglutethimide versus tamoxifen in metastatic breast cancer.
Lipton A; Harvey HA; Santen RJ; Boucher A; White D; Bernath A; Dixon R; Richards G; Shafik A
Cancer Res; 1982 Aug; 42(8 Suppl):3434s-3436s. PubMed ID: 7044526
[TBL] [Abstract][Full Text] [Related]
30. Are all aromatase inhibitors the same? A review of controlled clinical trials in breast cancer.
Berry J
Clin Ther; 2005 Nov; 27(11):1671-84. PubMed ID: 16368441
[TBL] [Abstract][Full Text] [Related]
31. Progestins and breast cancer.
Pasqualini JR
Gynecol Endocrinol; 2007 Oct; 23 Suppl 1():32-41. PubMed ID: 17943537
[TBL] [Abstract][Full Text] [Related]
32. Premenopausal breast cancer patients treated with a gonadotropin-releasing hormone analog alone or in combination with an aromatase inhibitor: a comparative endocrine study.
Celio L; Martinetti A; Ferrari L; Buzzoni R; Mariani L; Miceli R; Seregni E; Procopio G; Cassata A; Bombardieri E; Bajetta E
Anticancer Res; 1999; 19(3B):2261-8. PubMed ID: 10472341
[TBL] [Abstract][Full Text] [Related]
33. Aromatase inhibitors and breast cancer.
Brodie AM; Njar VC
Semin Oncol; 1996 Aug; 23(4 Suppl 9):10-20. PubMed ID: 8824460
[TBL] [Abstract][Full Text] [Related]
34. [Local production of estrogen via aromatase and estrone sulfatase in breast cancer tissue].
Utsumi T
Nihon Geka Gakkai Zasshi; 1989 Jun; 90(6):920-7. PubMed ID: 2796962
[TBL] [Abstract][Full Text] [Related]
35. Endogenous aromatization of testosterone results in growth stimulation of the human MCF-7 breast cancer cell line.
Sonne-Hansen K; Lykkesfeldt AE
J Steroid Biochem Mol Biol; 2005 Jan; 93(1):25-34. PubMed ID: 15748829
[TBL] [Abstract][Full Text] [Related]
36. Aromatase inhibitors in breast cancer.
Hiscox S; Davies EL; Barrett-Lee P
Maturitas; 2009 Aug; 63(4):275-9. PubMed ID: 19577386
[TBL] [Abstract][Full Text] [Related]
37. Endocrine therapy of breast and prostate cancer.
Manni A
Endocrinol Metab Clin North Am; 1989 Jun; 18(2):569-92. PubMed ID: 2663486
[TBL] [Abstract][Full Text] [Related]
38. [Growth inhibition of MCF-7 human breast cancer cells by aromatase inhibitors].
Fukuoka M; Kitawaki J; Yamamoto T; Okada H
Nihon Sanka Fujinka Gakkai Zasshi; 1991 Dec; 43(12):1667-73. PubMed ID: 1836000
[TBL] [Abstract][Full Text] [Related]
39. Aromatase in aging women.
Bulun SE; Zeitoun K; Sasano H; Simpson ER
Semin Reprod Endocrinol; 1999; 17(4):349-58. PubMed ID: 10851574
[TBL] [Abstract][Full Text] [Related]
40. Concentrations of estrone, estradiol, and estrone sulfate and evaluation of sulfatase and aromatase activities in pre- and postmenopausal breast cancer patients.
Pasqualini JR; Chetrite G; Blacker C; Feinstein MC; Delalonde L; Talbi M; Maloche C
J Clin Endocrinol Metab; 1996 Apr; 81(4):1460-4. PubMed ID: 8636351
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
